Analysis of Operational Excellence in the UK Pharmaceutical Industry
VerifiedAdded on 2025/04/29
|8
|2053
|183
AI Summary
Desklib provides past papers and solved assignments for students. This report analyzes operational excellence in the UK pharmaceutical industry.

OPERATION EXCELLENCE
PHARMACEUTICAL INDUSTRY
PHARMACEUTICAL INDUSTRY
Paraphrase This Document
Need a fresh take? Get an instant paraphrase of this document with our AI Paraphraser

1
INTRODUCTION
The report analyzed the key features of the operational excellence model which is used for
creating sustainable development and improvements within an organization. The
pharmaceutical industry of the United Kingdom is taken for describing the role of
operational excellence within a company. The parameters which are included in the
operational excellence model include process, people, product, and culture. The operational
excellence model is utilized for improving the growth and performance of the industry. The
operational excellence model is the combination of various models which are used for
describing the external and internal environment of a company. Different models such as
Porter’s Five Forces Model, Ansoff Matrix, Value Chain Model, Quality Management, and
Bowman Model. The pharmaceutical industry of the United Kingdom serves a large number
of people and contribute around £8.4 billion to the GDP of the UK. The business model of
the report is utilized to improve the current position of the industry.
INTRODUCTION
The report analyzed the key features of the operational excellence model which is used for
creating sustainable development and improvements within an organization. The
pharmaceutical industry of the United Kingdom is taken for describing the role of
operational excellence within a company. The parameters which are included in the
operational excellence model include process, people, product, and culture. The operational
excellence model is utilized for improving the growth and performance of the industry. The
operational excellence model is the combination of various models which are used for
describing the external and internal environment of a company. Different models such as
Porter’s Five Forces Model, Ansoff Matrix, Value Chain Model, Quality Management, and
Bowman Model. The pharmaceutical industry of the United Kingdom serves a large number
of people and contribute around £8.4 billion to the GDP of the UK. The business model of
the report is utilized to improve the current position of the industry.

2
OVERVIEW OF BUSINESS EXCELLENCE MODEL
The business model for the pharmaceutical industry of the United Kingdom is made with a
motive to improve the current performance of the industry. The current issues faced by the
industry are resolved with the help of the models discussed in the report. The operational
excellence model is prepared by the combination of a number of different models such as
Porter’s Five Forces Model, Ansoff Matrix, Value Chain Model, Quality Management, and
Bowman Model. The pharmaceutical industry of the United Kingdom is the fifth-sixth largest
pharmaceutical company in the world in terms of market share. In this model, the
components and strengths of different models are combined with each other for developing
a strategic business decision for the pharmaceutical industry. People, process, culture,
improvement, innovative design, customers and strategy are some of the main components
of the pharmaceutical industry.
The model designed in the report is named as ‘Business Amelioration Model’ which focused
on improving the current performance of the pharmaceutical industries. Porter’s Five Forces
Model used for analyzing the competitive position of the pharmaceutical industry (Rouse,
2014). Ansoff matrix is the marketing planning model which will describe growth strategies
that can be used by the pharmaceutical industry. Value Chain Model will discuss the various
range of activities that can be utilized by the pharmaceutical sector. Quality management is
the tool which will describe the standard level of excellence that the pharmaceutical sector
should achieve. The shortfalls of quality and process in the supply chain should be identified
with the help of total quality management.
KEY PRINCIPLES OF BUSINESS MODEL
The Business Amelioration Model has been described as a combination of different models
which are optimized for enhancing the current and future success of the pharmacy business
in the United Kingdom. The model has been designed innovatively to conduct the market
analysis of the condition of the pharmaceutical industry. Different principles are chosen
carefully in analyzing factors that hinder and foster the performance of the pharmaceutical
companies. The growth and performance of the pharmaceutical sector can be improved by
providing quality products and services to the customers. The cost of the products can be
OVERVIEW OF BUSINESS EXCELLENCE MODEL
The business model for the pharmaceutical industry of the United Kingdom is made with a
motive to improve the current performance of the industry. The current issues faced by the
industry are resolved with the help of the models discussed in the report. The operational
excellence model is prepared by the combination of a number of different models such as
Porter’s Five Forces Model, Ansoff Matrix, Value Chain Model, Quality Management, and
Bowman Model. The pharmaceutical industry of the United Kingdom is the fifth-sixth largest
pharmaceutical company in the world in terms of market share. In this model, the
components and strengths of different models are combined with each other for developing
a strategic business decision for the pharmaceutical industry. People, process, culture,
improvement, innovative design, customers and strategy are some of the main components
of the pharmaceutical industry.
The model designed in the report is named as ‘Business Amelioration Model’ which focused
on improving the current performance of the pharmaceutical industries. Porter’s Five Forces
Model used for analyzing the competitive position of the pharmaceutical industry (Rouse,
2014). Ansoff matrix is the marketing planning model which will describe growth strategies
that can be used by the pharmaceutical industry. Value Chain Model will discuss the various
range of activities that can be utilized by the pharmaceutical sector. Quality management is
the tool which will describe the standard level of excellence that the pharmaceutical sector
should achieve. The shortfalls of quality and process in the supply chain should be identified
with the help of total quality management.
KEY PRINCIPLES OF BUSINESS MODEL
The Business Amelioration Model has been described as a combination of different models
which are optimized for enhancing the current and future success of the pharmacy business
in the United Kingdom. The model has been designed innovatively to conduct the market
analysis of the condition of the pharmaceutical industry. Different principles are chosen
carefully in analyzing factors that hinder and foster the performance of the pharmaceutical
companies. The growth and performance of the pharmaceutical sector can be improved by
providing quality products and services to the customers. The cost of the products can be
⊘ This is a preview!⊘
Do you want full access?
Subscribe today to unlock all pages.

Trusted by 1+ million students worldwide

3
reduced by cutting down the middlemen and intermediaries in the pharmaceutical supply
chain. The manufacturing process can be improved by enhancing technology which will help
in reducing product cost and the products and services of the pharmaceutical sector can be
sold at the competitive prices in the market.
The company can promote its products by providing quality products to its customers
because it is the only method by which the pharmaceutical sector can maximize its sales.
There are no additional marketing options available for the pharmaceutical companies of
the UK. The quality products provided by the pharmaceutical company make it competitive
in the industry and help it in earning high profits. Thus the companies of the pharmaceutical
sector should concern about improving the quality of its products as well as services.
The model is developed with an aim to provide different measures for improving the work
performance of the pharmaceutical companies in order to satisfy the needs and demands of
e customers. The continuous growth and development of the pharmaceutical industry can
be ensured with the successful application of various model discussed in the report. The
Business Amelioration Model will determine different principle and business strategies
which will increase the future growth prospects and improvement in the process of the
pharmaceutical industry. The business excellence framework of the pharmaceutical sector
of the United Kingdom can be achieved by reducing the cost of products and services by
decreasing expenses of production. Continuous quality improvement method can be used
for maintaining the effective quality of the products and processes of the pharmaceutical
company.
The main principles of the Business Amelioration Model are described as follows:
To increase the competitive position of the pharmaceutical industry by providing a
brief description of Porter’s Five Forces Model along with an analysis of the strengths
and weaknesses of the current market position of the company.
The model will increase the quality performance of the pharmaceutical companies
by improving the quality of products and services and serving the needs and
demands of the customers.
Customer-driven strategies will ensure sustainable development in the
pharmaceutical sector by satisfying the demands of the customers.
reduced by cutting down the middlemen and intermediaries in the pharmaceutical supply
chain. The manufacturing process can be improved by enhancing technology which will help
in reducing product cost and the products and services of the pharmaceutical sector can be
sold at the competitive prices in the market.
The company can promote its products by providing quality products to its customers
because it is the only method by which the pharmaceutical sector can maximize its sales.
There are no additional marketing options available for the pharmaceutical companies of
the UK. The quality products provided by the pharmaceutical company make it competitive
in the industry and help it in earning high profits. Thus the companies of the pharmaceutical
sector should concern about improving the quality of its products as well as services.
The model is developed with an aim to provide different measures for improving the work
performance of the pharmaceutical companies in order to satisfy the needs and demands of
e customers. The continuous growth and development of the pharmaceutical industry can
be ensured with the successful application of various model discussed in the report. The
Business Amelioration Model will determine different principle and business strategies
which will increase the future growth prospects and improvement in the process of the
pharmaceutical industry. The business excellence framework of the pharmaceutical sector
of the United Kingdom can be achieved by reducing the cost of products and services by
decreasing expenses of production. Continuous quality improvement method can be used
for maintaining the effective quality of the products and processes of the pharmaceutical
company.
The main principles of the Business Amelioration Model are described as follows:
To increase the competitive position of the pharmaceutical industry by providing a
brief description of Porter’s Five Forces Model along with an analysis of the strengths
and weaknesses of the current market position of the company.
The model will increase the quality performance of the pharmaceutical companies
by improving the quality of products and services and serving the needs and
demands of the customers.
Customer-driven strategies will ensure sustainable development in the
pharmaceutical sector by satisfying the demands of the customers.
Paraphrase This Document
Need a fresh take? Get an instant paraphrase of this document with our AI Paraphraser

4
To create a strategic business policy for developing an innovative environment for
the best healthcare outcomes of the pharmaceutical industry.
KEY ELEMENTS OF THE MODEL
The Business Amelioration Model has been designed with a motive of building core
functionality of the pharmaceutical sector of the United Kingdom country. The business
performance of the company can be evaluated by using a set of models discussed. The
market position of the pharmaceutical industry can be carried out by the company with the
help of various research and development activities. The pharmaceutical industry is making
a huge investment in the R&D process which improve the performance of the company.
There are five main elements of the Business Amelioration Model which will describe the
core performance of the pharmaceutical industry and suggest the areas for improvement.
Different theories and models can be used by the company for building an effective model
for utilizing the market opportunities and improving the current performances.
The pharmaceutical industry of the UK is employing a maximum number of employees as
compared to the other nations of the world. There are around 281440 people employed by
pharmaceutical sector of the United Kingdom in the year 2016, while there are 73000
employees are working at the pharmaceutical sector of Germany in the year 2017 and
114000 in the year 2015. The pharmaceutical industry of the UK contributes around £8.4
billion in the GDP of the country. The pharmaceutical industry of the United Kingdom is the
fifth-sixth largest pharmaceutical company in the world in terms of market share. The
pharmaceutical sector of UK contributed by developing one of the five world’s biggest
selling prescription drugs. The Business Amelioration Model aims at improving the quality of
performance in the pharmaceutical sector so as to increase the overall growth and
profitability of the company. The pharmaceutical companies of UK spend around £3.9 billion
in the research and development which help them in improving the quality of the medicines
and other drugs provided by the companies. Innovation and research are an essential
criterion which brings quality improvement with the help of scientific innovations and
designs. The sales can be increased by fulfilling customers demand and by providing quality
goods. The services of the pharmaceutical sector of the UK should be provided with
increased efficiency. The pharmaceutical industry should provide various options of
To create a strategic business policy for developing an innovative environment for
the best healthcare outcomes of the pharmaceutical industry.
KEY ELEMENTS OF THE MODEL
The Business Amelioration Model has been designed with a motive of building core
functionality of the pharmaceutical sector of the United Kingdom country. The business
performance of the company can be evaluated by using a set of models discussed. The
market position of the pharmaceutical industry can be carried out by the company with the
help of various research and development activities. The pharmaceutical industry is making
a huge investment in the R&D process which improve the performance of the company.
There are five main elements of the Business Amelioration Model which will describe the
core performance of the pharmaceutical industry and suggest the areas for improvement.
Different theories and models can be used by the company for building an effective model
for utilizing the market opportunities and improving the current performances.
The pharmaceutical industry of the UK is employing a maximum number of employees as
compared to the other nations of the world. There are around 281440 people employed by
pharmaceutical sector of the United Kingdom in the year 2016, while there are 73000
employees are working at the pharmaceutical sector of Germany in the year 2017 and
114000 in the year 2015. The pharmaceutical industry of the UK contributes around £8.4
billion in the GDP of the country. The pharmaceutical industry of the United Kingdom is the
fifth-sixth largest pharmaceutical company in the world in terms of market share. The
pharmaceutical sector of UK contributed by developing one of the five world’s biggest
selling prescription drugs. The Business Amelioration Model aims at improving the quality of
performance in the pharmaceutical sector so as to increase the overall growth and
profitability of the company. The pharmaceutical companies of UK spend around £3.9 billion
in the research and development which help them in improving the quality of the medicines
and other drugs provided by the companies. Innovation and research are an essential
criterion which brings quality improvement with the help of scientific innovations and
designs. The sales can be increased by fulfilling customers demand and by providing quality
goods. The services of the pharmaceutical sector of the UK should be provided with
increased efficiency. The pharmaceutical industry should provide various options of

5
treatment along with allopathic medicines. The Business Amelioration Model is developed
with a combination of various elements of the pharmaceutical sector that need
improvement. This will result in high effectiveness and efficiency in growth and success of
the pharmaceutical companies. The different stages of Business Amelioration Model which
explains the different models are explained as follows:
PRODUCT ASSESSMENT
Product judgment or assessment is the initial stage of the Business Amelioration Model
which will help in identifying the current performance of the company’s products and
services. The areas of improvement can be evaluated in the stage of product assessment for
quality improvement of the products. The pharmaceutical companies require continues
improvement and development in the products and services in order to fulfill the demands
of the customers. Product development is an essential factor of the pharmaceutical industry
which includes qualitative research and quantitative research for the purpose of product
assessment. New product development or NPD is a common strategy which can be used by
the pharmaceutical companies of the pharmaceutical industry of UK for dealing with the
fast-growing market situation and to remain competitive in the market (Yousefi, et. al,
2017). The product assessment and development can be done by the pharmaceutical sector
of the UK by using the Value chain model as a part of the whole Business Amelioration
Model. Research and development is a very essential feature of the product development in
the pharmaceutical sector which is analyzed in the Business Amelioration Model. The basic
medicines and essential drugs as prescribed by the medical experts, doctors, and other
specialists should be made available to the people. The location and period of availability
are other main aspects of the product evaluation and assessment stage of the Business
Amelioration Model. Following is the application of the value chain model for analyzing the
product performance and the need for improvement in the products and services of the
pharmaceutical sector of the UK:
VALUE CHAIN MODEL
Value chain model is a tool which analyzes the key capabilities and performance level for
bringing the products and services from conception to delivery (Harrison, 2018). The value
chain analysis is the combination of various activities from production, design,
treatment along with allopathic medicines. The Business Amelioration Model is developed
with a combination of various elements of the pharmaceutical sector that need
improvement. This will result in high effectiveness and efficiency in growth and success of
the pharmaceutical companies. The different stages of Business Amelioration Model which
explains the different models are explained as follows:
PRODUCT ASSESSMENT
Product judgment or assessment is the initial stage of the Business Amelioration Model
which will help in identifying the current performance of the company’s products and
services. The areas of improvement can be evaluated in the stage of product assessment for
quality improvement of the products. The pharmaceutical companies require continues
improvement and development in the products and services in order to fulfill the demands
of the customers. Product development is an essential factor of the pharmaceutical industry
which includes qualitative research and quantitative research for the purpose of product
assessment. New product development or NPD is a common strategy which can be used by
the pharmaceutical companies of the pharmaceutical industry of UK for dealing with the
fast-growing market situation and to remain competitive in the market (Yousefi, et. al,
2017). The product assessment and development can be done by the pharmaceutical sector
of the UK by using the Value chain model as a part of the whole Business Amelioration
Model. Research and development is a very essential feature of the product development in
the pharmaceutical sector which is analyzed in the Business Amelioration Model. The basic
medicines and essential drugs as prescribed by the medical experts, doctors, and other
specialists should be made available to the people. The location and period of availability
are other main aspects of the product evaluation and assessment stage of the Business
Amelioration Model. Following is the application of the value chain model for analyzing the
product performance and the need for improvement in the products and services of the
pharmaceutical sector of the UK:
VALUE CHAIN MODEL
Value chain model is a tool which analyzes the key capabilities and performance level for
bringing the products and services from conception to delivery (Harrison, 2018). The value
chain analysis is the combination of various activities from production, design,
⊘ This is a preview!⊘
Do you want full access?
Subscribe today to unlock all pages.

Trusted by 1+ million students worldwide

6
manufacturing to marketing and distribution of goods and services of a company (Business
Dictionary, 2019). The model of value chain analysis comprises of a set of management and
organizing activities which are used for ensuring quality delivery in the form of products and
services by the pharmaceutical sector of the UK.
The pharmaceutical industry of UK has played an important role in providing required drugs
and treatment with the help of analytical science. Following are the stages covered in the
initial stage of the Business Amelioration Model:
Primary activities
The primary activities will include inbound logistics, operations, outbound logistics,
marketing and sales, and service as its main areas which will help in delivering creative and
innovative products to the customers. Following are the components of the primary
activities which can be used by the pharmaceutical sector of the UK:
Inbound logistics
The suppliers from which the raw materials can be acquired by the company for
manufacturing their final products are included in the inbound logistics. The
availability of raw materials will result in no drug shortages in the pharmaceutical
sector of the UK. A close check is needed to be maintained by the company on the
suppliers and volume volatility of the products of the company. The specific supplies
needed by the pharmaceutical industry should be continuously maintained by the
companies for ensuring timely delivery of required drugs and medicines to the
customers. Raw material supplier failure can result in a major disaster for the
pharmaceutical sector which will bring rise to other issues as well. Inventory stock
holding is a frustrating task for the manufacturer and thus a close check on the
inventories and supplies of the pharmaceutical companies is required.
Operations
Operations is a stage where the raw materials are converted into final goods and
products of the company.
Outbound Logistics
Marketing and sales
Services
manufacturing to marketing and distribution of goods and services of a company (Business
Dictionary, 2019). The model of value chain analysis comprises of a set of management and
organizing activities which are used for ensuring quality delivery in the form of products and
services by the pharmaceutical sector of the UK.
The pharmaceutical industry of UK has played an important role in providing required drugs
and treatment with the help of analytical science. Following are the stages covered in the
initial stage of the Business Amelioration Model:
Primary activities
The primary activities will include inbound logistics, operations, outbound logistics,
marketing and sales, and service as its main areas which will help in delivering creative and
innovative products to the customers. Following are the components of the primary
activities which can be used by the pharmaceutical sector of the UK:
Inbound logistics
The suppliers from which the raw materials can be acquired by the company for
manufacturing their final products are included in the inbound logistics. The
availability of raw materials will result in no drug shortages in the pharmaceutical
sector of the UK. A close check is needed to be maintained by the company on the
suppliers and volume volatility of the products of the company. The specific supplies
needed by the pharmaceutical industry should be continuously maintained by the
companies for ensuring timely delivery of required drugs and medicines to the
customers. Raw material supplier failure can result in a major disaster for the
pharmaceutical sector which will bring rise to other issues as well. Inventory stock
holding is a frustrating task for the manufacturer and thus a close check on the
inventories and supplies of the pharmaceutical companies is required.
Operations
Operations is a stage where the raw materials are converted into final goods and
products of the company.
Outbound Logistics
Marketing and sales
Services
Paraphrase This Document
Need a fresh take? Get an instant paraphrase of this document with our AI Paraphraser

7
Support activities
The support activities help in developing the competitive advantage of the company in the
market by assisting the primary activities. The main areas of the support activities include
procurement, technology development (including Research & Development), human
resource management, and infrastructure. This also includes different systems for planning,
information management, finance, quality, etc.
MARKET RESEARCH AND EXPLORATION
Rouse, M., 2014. Porter's Five Forces. (Online) Available at:
https://searchcio.techtarget.com/definition/Porters-Five-Forces (Accessed on 15th April,
2019).
Business Dictionary, 2019. Value chain. (Online) Available at:
http://www.businessdictionary.com/definition/value-chain.html (Accessed on 15th April,
2019).
Harrison, K., 2018. What Is a Value Chain Analysis? (Online) Available at:
https://www.businessnewsdaily.com/5678-value-chain-analysis.html (Accessed on 15th
April, 2019).
Yousefi, N., Mehralian, G., Rasekh, H. R. and Yousefi, M., 2017. (Online) Available at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603895/ (Accessed on 15th April, 2019).
Support activities
The support activities help in developing the competitive advantage of the company in the
market by assisting the primary activities. The main areas of the support activities include
procurement, technology development (including Research & Development), human
resource management, and infrastructure. This also includes different systems for planning,
information management, finance, quality, etc.
MARKET RESEARCH AND EXPLORATION
Rouse, M., 2014. Porter's Five Forces. (Online) Available at:
https://searchcio.techtarget.com/definition/Porters-Five-Forces (Accessed on 15th April,
2019).
Business Dictionary, 2019. Value chain. (Online) Available at:
http://www.businessdictionary.com/definition/value-chain.html (Accessed on 15th April,
2019).
Harrison, K., 2018. What Is a Value Chain Analysis? (Online) Available at:
https://www.businessnewsdaily.com/5678-value-chain-analysis.html (Accessed on 15th
April, 2019).
Yousefi, N., Mehralian, G., Rasekh, H. R. and Yousefi, M., 2017. (Online) Available at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603895/ (Accessed on 15th April, 2019).
1 out of 8
Related Documents

Your All-in-One AI-Powered Toolkit for Academic Success.
+13062052269
info@desklib.com
Available 24*7 on WhatsApp / Email
Unlock your academic potential
Copyright © 2020–2025 A2Z Services. All Rights Reserved. Developed and managed by ZUCOL.